Weill Cornell Medicine Urology
Weill Cornell Medicine Urology
Prostate Cancer

Prostate Cancer

Header Text: 

Dr. Jim C. Hu leads the LeFrak Center for Robotic Surgery, where we provide the most advanced treatment options available for prostate cancer. 

Intro/Headline: 

Body: 

What Is Prostate Cancer

Prostate cancer is the most commonly diagnosed solid organ tumor in men in the United States, with one of seven men developing this disease over their lifetime. In 2017, it is estimated that over 160,000 men will be diagnosed with prostate cancer, and more than 26,000 men will die from it. Prostate cancer is the second leading cause of cancer death in men after lung cancer.

A diagnosis of prostate cancer may lead to anxiety, and the treatment of prostate cancer may affect quality-of-life, with risks of urinary incontinence and erectile dysfunction. However, PSA screening for prostate cancer can decrease the risk of death dramatically. Therefore, a man's age, overall health, and life expectancy are critical considerations when considering whether to pursue PSA testing for prostate cancer diagnosis and treatment. The decision to pursue PSA screening and/or subsequent treatment are individualized patient decisions that are best made with the help of an expert in this condition.

In recent years, PSA testing alone has been supplanted by a number of secondary tests that can help better determine whether men are at risk of the more aggressive prostate cancers that can cause death. Although detection of prostate cancer requires a biopsy to make a firm diagnosis, blood tests such as the 4kScore test, urine analysis such as PCA3, and imaging using multiparametric prostate MRI can help determine whether a prostate biopsy is even needed. In addition, it is important to remember that many men may have an elevated PSA for other reasons than prostate cancer. In other cases, a diagnosis of prostate cancer may be made, but the cancer may be of such low risk to the patient that the prostate cancer that may be observed rather than aggressively treated, a process referred to as active surveillance.

Breaking News for Prostate Cancer:

The risk of developing prostate cancer is not increased by testosterone therapy, despite widespread concern for the link of prostate disease and hormones.

Revised Recommendations for PSA Testing

First Clinical Trial of New Targeted Molecular Therapy in U.S. Takes Aim at Incurable Prostate Cancer

 

Body Column 2: 

Surviving Prostate Cancer

Early detection is key. The sooner a patient can receive prostate cancer treatment, the better the outcome. Frequent prostate cancer screening can help when it comes to spotting the cancer quickly. If you've recently been diagnosed with the disease, it's important to schedule an appointment with a prostate cancer specialist in New York as soon as possible. Wherever you live in New York— Manhattan, Brooklyn, Queens—Weill Cornell can accommodate your needs.

What Causes Prostate Cancer?

Both environmental influences and genetics can predispose men to develop prostate cancer. Since prostate cancer is one of the most genetically-determined cancers, consideration of your family history of prostate cancer (father, brothers affected by disease) is critical to effectively monitor for this disease. Weill Cornell Medicine is a global leader in prostate cancer research, with notable achievements including identification of the SPOP mutation that is now recognizes to create about 10% of all prostate cancers. In addition, our investigators have identified the role of Prostate Specific Membrane Antigen (PSMA) in detection and management of prostate cancers. While several different pathways to development of prostate cancer are evidently present, we know that changes in the DNA of prostate cells can sometimes lead to abnormal development and cancerous growths. Risk factors for such changes include high fat diets, low vitamin D levels, and other environmental exposures, in addition to genetics.

Dealing with Prostate Cancer

A man's age, overall health, prostate cancer histology (Gleason Grade), extent of tumor and life expectancy are critical considerations when considering prostate cancer treatment. In addition to our expertise in robotic prostate cancer surgery, Weill Cornell Medicine offers expert care for patients in New York under active surveillance (also known as watchful waiting), minimally invasive therapies including High Intensity Focused Ultrasound (HIFU) and cryotherapy, as well as state-of-the-art radiation therapies & chemotherapy. The decision to pursue and select treatment(s) is an individualized one that our experts in this condition are available to help guide you through. We have a multi-disciplinary team for patient care that involves world-leading experts in surgery, minimally invasive therapies, radiation, and other approaches including our experts in medical (urologic) oncology, urology, radiology, pathology and radiation therapy.

Prostate Cancer - Risks & Causes

Summary: 

While direct causes for the incidence of prostate cancer remain unclear, research suggests that an individual's age, race, and body weight all have impacts on the likelihood of diagnosis. You can learn more about your specific risks from a urologist at Weill Cornell Medicine.

Learn More

Prostate Cancer - Diagnosis

Summary: 

Most prostate cancers in the United States are detected through prostate cancer screening, comprised of a digital rectal exam and a blood test for Prostate Specific Antigen (PSA). The use of PSA screening is an individualized decision that should be discussed with family members, primary care doctors and urologists.

Learn More

Prostate Cancer - Treatment Options

Summary: 

Some patients with low risk prostate cancer may choose to forgo or postpone treatment, opting for active surveillance via PSA testing, biopsies, and imaging. If this monitoring determines a high risk, Brady Urology helps our patients decide which treatment options are best for them.

Learn More

Physicians & Faculty

Dr. Peter N. Schlegel, MD, FACS | Cornell Urology

Peter N. Schlegel

M.D., F.A.C.S.

212.746.5491
212.746.5491
Aetna-Weill Cornell POS, Medicaid, Medicare, Rockefeller University-CoreSource
The LeFrak Center for Robotic Surgery

Jim C. Hu

M.D., M.P.H.

(646) 962-9600
(646) 962-9600
AETNA [Medicare], AETNA-HMO, AETNA-PPO, Aetna-Weill Cornell POS, Affinity Access, Affinity Essential, Affinity Health Plan, Blue Priority Network, CIGNA, EBCBS HMO, EBCBS Mediblue, EBCBS Pathway X, EBCBS Pathway X Enhanced, EBCBS PPO/EPO, Emblem Select Care, Empire BCBS HealthPlus, Empire BCBS HealthPlus (CHP), Fidelis Care, GHI, Health First, Health Insurance Plan of NY (HIP), Health Insurance Plan of NY (HIP) [Medicaid], Health Insurance Plan of NY (HIP) [Medicare], Medicaid, Medicare, Oxford Freedom, Oxford Health Plans [Liberty], Oxford Health Plans [Medicare], Oxford Health Plans [Metro/Core/Charter], POMCO, Rockefeller University-CoreSource, UHC Community Plan - Essential Plan, UHC Community Plan - Medicaid Plan, UHC Compass-HMO, UHC Medicare, United Empire Plan, United Healthcare Commercial, VNSNY CHOICE Medicare, VNSNY CHOICE SelectHealth
The LeFrak Center for Robotic Surgery
Dr. David Michael Nanus, M.D.

David M. Nanus

M.D.

646.962.2072
646.962.2072
AETNA [Medicare], AETNA-HMO, AETNA-PPO, Aetna-Weill Cornell POS, Affinity Health Plan, CIGNA, EBCBS HMO, EBCBS Mediblue, EBCBS PPO/EPO, GHI, Health Insurance Plan of NY (HIP), Health Insurance Plan of NY (HIP) [Medicaid], Health Insurance Plan of NY (HIP) [Medicare], Oxford Health Plans [Liberty], Rockefeller University-CoreSource, United Empire Plan, United Health Care, United Health Care [Community Plan]
Dr. Douglas S. Scherr, M.D. | Weill Cornell Medicine

Douglas Scherr

M.D.

212.746.5788
212.746.5788
AETNA [Medicare], AETNA-HMO, AETNA-PPO, Aetna-Weill Cornell POS, CIGNA, EBCBS HMO, EBCBS Mediblue, EBCBS PPO/EPO, Empire BCBS HealthPlus, Empire BCBS HealthPlus (CHP), GHI, Health Insurance Plan of NY (HIP), Health Insurance Plan of NY (HIP) [Medicare], Medicaid, Medicare, Rockefeller University-CoreSource, United Empire Plan, United Healthcare Commercial
Brady Urologic Health Center
Dr. Scott T. Tagawa, M.D., MS

Scott T. Tagawa

M.D.

646.962.2072
646.962.2072
AETNA [Medicare], AETNA-HMO, AETNA-PPO, Aetna-Weill Cornell POS, Affinity Access, Affinity Health Plan, Blue Priority Network, CIGNA, EBCBS HMO, EBCBS Mediblue, EBCBS Pathway X, EBCBS PPO/EPO, Emblem Select Care, Empire BCBS HealthPlus, Empire BCBS HealthPlus (CHP), Fidelis Care, GHI, Health First, Health Insurance Plan of NY (HIP), Health Insurance Plan of NY (HIP) [Medicaid], Health Insurance Plan of NY (HIP) [Medicare], Medicaid, Medicare, Oxford Freedom, Oxford Health Plans [Liberty], Oxford Health Plans [Medicare], Oxford Health Plans [Metro/Core/Charter], POMCO, Rockefeller University-CoreSource, UHC Compass, United Empire Plan, United Health Care, United Health Care [Community Plan], United Healthcare Commercial, VNSNY CHOICE Medicare, VNSNY CHOICE SelectHealth
Dr. Christopher Barbieri, M.D., Ph.D | Cornell Urology

Christopher E. Barbieri

M.D., Ph.D.

212.746.5562
212.746.5562
AETNA [Medicare], AETNA-HMO, AETNA-PPO, Aetna-Weill Cornell POS, Affinity Access, Affinity Essential, Affinity Health Plan, Blue Priority Network, CIGNA, EBCBS HMO, EBCBS Mediblue, EBCBS Pathway X, EBCBS Pathway X Enhanced, EBCBS PPO/EPO, Emblem Select Care, Empire BCBS HealthPlus, Empire BCBS HealthPlus (CHP), Fidelis Care, GHI, Health First, Health Insurance Plan of NY (HIP), Health Insurance Plan of NY (HIP) [Medicaid], Health Insurance Plan of NY (HIP) [Medicare], Medicaid, Medicare, Oxford Freedom, Oxford Health Plans [Liberty], Oxford Health Plans [Medicare], Oxford Health Plans [Metro/Core/Charter], Rockefeller University-CoreSource, UHC Community Plan - Essential Plan, UHC Community Plan - Medicaid Plan, UHC Compass-HMO, UHC Medicare, United Empire Plan, United Healthcare Commercial, VNSNY CHOICE Medicare, VNSNY CHOICE SelectHealth
Brady Urologic Health Center
Dr. Himisha Beltran, M.D.

Himisha Beltran

M.D.

212.746.5449
212.746.5449
AETNA [Medicare], AETNA-HMO, AETNA-PPO, Aetna-Weill Cornell POS, CIGNA, EBCBS HMO, EBCBS Mediblue, EBCBS PPO/EPO, Health First, Health Insurance Plan of NY (HIP), Health Insurance Plan of NY (HIP) [Medicaid], Health Insurance Plan of NY (HIP) [Medicare], Oxford Freedom, Oxford Health Plans [Liberty], Oxford Health Plans [Medicare], Rockefeller University-CoreSource, United Empire Plan, United Health Care, United Health Care [Community Plan]
Dr. Scott G. David, M.D.

Scott G. David

M.D.

646.962.9600
646.962.9600
Aetna-Weill Cornell POS, Affinity Access, Affinity Essential, Affinity Health Plan, EBCBS NYPH Employees Only, Empire BCBS HealthPlus, Empire BCBS HealthPlus (CHP), Fidelis Care, Health First, Health Insurance Plan of NY (HIP) [Medicaid], Medicaid, Medicare, POMCO, Rockefeller University-CoreSource, VNSNY CHOICE Medicare, VNSNY CHOICE SelectHealth
Brady Urologic Health Center

Timothy McClure

M.D.

646.962.9600
646.962.9600
AETNA [Medicare], AETNA-HMO, AETNA-PPO, Aetna-Weill Cornell POS, Affinity Access, Affinity Essential, Affinity Health Plan, Blue Priority Network, CIGNA, EBCBS HMO, EBCBS Mediblue, EBCBS Pathway X, EBCBS Pathway X Enhanced, EBCBS PPO/EPO, Empire BCBS HealthPlus, Empire BCBS HealthPlus (CHP), Fidelis Care, GHI, Health First, Medicare, Oxford Freedom, Oxford Health Plans [Liberty], Oxford Health Plans [Medicare], Oxford Health Plans [Metro/Core/Charter], POMCO, Rockefeller University-CoreSource, UHC Community Plan - Essential Plan, UHC Community Plan - Medicaid Plan, UHC Medicare, United Healthcare Commercial, VNSNY CHOICE Medicare, VNSNY CHOICE SelectHealth
The LeFrak Center for Robotic Surgery
Multimedia

Multimedia

© 2016 Weill Cornell Medicine All rights reserved.